NeoGenomics (NEO) Stock Price Target 2026

The average analyst price target for NeoGenomics is $17.93, 1.9% above the current price. Of 13 analysts, 11 rate it Buy and 2 Hold. Targets range from $8 to $28. The latest change came on Oct 29, 2026, when TD Cowen raised its price target on NeoGenomics from $19 to $23 and kept a Buy rating.

The Average Analyst Price Target for NeoGenomics is $17.93.

Price Target Range — 12 Quarters

Analyst Consensus — 13 Analysts

11Buy

2Hold

Consensus RatingBuy# Analysts13Avg. Consensus PT$17.93Upside to Avg. PT+1.9%

Rating Trend — Last 9 Months

Latest Upgrades and Downgrades for NeoGenomics Stock

See all ratings →

Date	Firm	Analyst	Action	Rating Change	Price Target
Oct 29, 2026	TD Cowen	Dan Brennan	PT Raise	Buy	$19→$23
Oct 29, 2026	BTIG	Mark Massaro	Maintained	Buy	$28
Oct 6, 2026	StoneX	Bruce D. Jackson	PT Raise	Buy	$16→$20
Oct 6, 2026	Needham	Mike Matson	PT Raise	Buy	$19→$22
Oct 6, 2026	BTIG	Mark Massaro	Upgrade	Neutral→Buy	$28
Jul 29, 2026	Needham	Mike Matson	PT Raise	Buy	$15→$19
Jul 24, 2026	Benchmark	Bruce D. Jackson	PT Raise	Buy	$11→$16
Apr 29, 2026	Benchmark	Bruce Jackson	Upgrade	Hold→Buy	$11
Apr 29, 2026	TD Cowen	Dan Brennan	PT Raise	Buy	$13→$14
Apr 29, 2026	Leerink Partners	Puneet Souda	Upgrade	Market Perform→Outperform	$12→$25
Feb 24, 2026	Piper Sandler	David Westenberg	PT Raise	Overweight	$12→$13
Feb 17, 2026	Needham	Mike Matson	PT Raise	Buy	$14→$15
Jan 12, 2026	Needham	Mike Matson	Maintained	Buy	$14
Sep 12, 2025	TD Cowen	Dan Brennan	PT Raise	Buy	$10→$12
Sep 2, 2025	Stephens & Co.	Mason Carrico	PT Raise	Overweight	$7→$11
Aug 29, 2025	Needham	Mike Matson	PT Raise	Buy	$8→$14
Aug 4, 2025	Piper Sandler	David Westenberg	PT Cut	Overweight	$12→$11
Jul 30, 2025	Morgan Stanley	Tejas Savant	PT Cut	Equal-Weight	$10→$8
Jul 29, 2025	Needham	Mike Matson	PT Cut	Buy	$9→$8
Jul 29, 2025	William Blair	—	Downgrade	Outperform→Market Perform	—